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Chevrier et al. (2010) assessed the association 
between 10 polybrominated diphenyl ethers 
(PBDEs) and free and total thyroxine (T4) 
and thyroid-stimulating hormone (TSH) in 
270 women around the 27th week of gesta-
tion. They concluded that PBDEs are associ-
ated with lower TSH levels during pregnancy, 
but several factors that likely influenced the 
results were not considered in their analysis.
Normal pregnancy can lead to low TSH 
levels without affecting T4 levels, as can several 
other factors (e.g., starvation; stress; psychia tric 
dis orders; depression; acute or chronic non-
thyroidal disorders; alterations in thyrotropin- 
releasing hormone, cortisol, opio dergic, dopa-
minergic, or somato statinergic activity; and 
altera tions in leptin and cytokine production) 
(Braverman and Utiger 2000; Krassas et al. 
2010). None of these were included in the 
analy ses of Chevrier et al. (2010), yet any of 
them could have contributed to lower TSH 
levels. 
Chevrier et al. (2010) classified women 
in their second and third trimesters as having 
subclinical hyper thyroidism if their serum 
TSH levels were < 0.5 mIU/L and < 0.8 
mIU/L, respectively. Krassas et al. (2010) 
recently reported TSH reference ranges: 5th 
percentiles for the second and third trimesters 
were 0.03–0.39 and 0.13 mIU/L, respectively, 
suggesting that the cutoffs used by Chevrier 
et al. (2010) led to an incorrect classification 
of at least some women. 
Chevrier et al. (2010) reported that blood 
was drawn at 27.3 ± 3.1 (mean ± SD) weeks 
gestation; however, it is unclear which women 
were in the second trimester and which were 
in the third trimester. Although Chevrier et al. 
(2010) adjusted for gestational age, the use 
of different cutoffs for a binary variable (sub-
clini cal hyper thyroidism) for women in the 
same analyses likely biased results, particularly 
considering that differences between women 
near the end of the second and beginning of 
the third trimester are not great. 
With the exception of a few outliers, the 
range of each PBDE among study subjects was 
quite small (all with the ratio of the 75th to 
the 25th percentile < 3.4). Because blood was 
drawn only once and all associations noted were 
quite weak, even a small difference between the 
measured PBDE level and the actual level in an 
individual could have biased the results.
All of the PBDE congeners were moder-
ately to strongly inter correlated (r = 0.6–0.9; 
p < 0.001), yet analyses were conducted only 
by individual congener, leaving the inappro-
priate impression that several of the PBDE 
congeners may have been causally associated 
with lower TSH levels.
The limitations discussed above preclude 
one from drawing conclusions regarding asso-
ciations between serum PBDEs and TSH. It is 
notable, however, that even if associations are 
shown to be causal, the decrements in TSH 
reported are very small and mostly within the 
reference range for pregnant women. Thus, they 
are unlikely to result in adverse health effects in 
either pregnant women or their fetuses. 
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Goodman et al. raise concerns regarding our 
study (Chevrier et al. 2010) in which we 
reported associations between serum levels of 
polybrominated diphenyl ethers (PBDEs) and 
lower thyroid-stimulating hormone (TSH) in 
pregnant women participating in the Center 
for the Health Assessment of Mothers and 
Children of Salinas (CHAMACOS) cohort 
study. The points they raise are unlikely to 
have affected the validity of our conclusion.
Goodman et al. correctly point out that, 
as for most health outcomes, thyroid hor-
mone levels may be affected by a number 
of factors. However, these factors must be 
related to PBDE serum levels to confound 
the associations that we reported. Although 
it would be of interest to evaluate associa-
tions between exposure to PBDEs and the 
adverse health effects cited by Goodman et al. 
(e.g., psychiatric dis orders, depression, neuro-
transmitter and hormonal alterations), we 
are aware of no study that investigated these 
relationships. Furthermore, should PBDEs 
cause these health effects, they would be on 
the causal pathway between exposure and dis-
ease, and as such, should not be adjusted for. 
Consequently, it is unlikely that the factors 
identified by Goodman et al. substantially 
confounded our results. On the other hand, 
we considered a large number of demo graphic 
and environmental factors that may be related 
to both PBDE serum levels and thyroid func-
tion, and we observed little confounding 
(Chevrier et al. 2010). 
Goodman et al. also suggest that our 
results may be due to exposure and outcome 
mis classi fication based on a) the reference 
range that we used to determine sub clinical 
hyper thyroidism; b) our use of different cut-
offs for women in the second and third tri-
mesters of pregnancy; and c) the fact that we 
measured PBDEs at one time point during 
pregnancy. As explained below, we believe 
that substantial mis classification is unlikely; 
even if misclassification did occur, it would 
most likely be nondifferential with regard to 
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